These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 20088810)

  • 1. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.
    Yurko-Mauro K
    Curr Alzheimer Res; 2010 May; 7(3):190-6. PubMed ID: 20088810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
    Yurko-Mauro K; McCarthy D; Rom D; Nelson EB; Ryan AS; Blackwell A; Salem N; Stedman M;
    Alzheimers Dement; 2010 Nov; 6(6):456-64. PubMed ID: 20434961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ω-3 fatty acids in the prevention of cognitive decline in humans.
    Cederholm T; Salem N; Palmblad J
    Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
    Quinn JF; Raman R; Thomas RG; Yurko-Mauro K; Nelson EB; Van Dyck C; Galvin JE; Emond J; Jack CR; Weiner M; Shinto L; Aisen PS
    JAMA; 2010 Nov; 304(17):1903-11. PubMed ID: 21045096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
    Hashimoto M; Hossain S
    J Pharmacol Sci; 2011; 116(2):150-62. PubMed ID: 21606627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older Adults.
    Jackson PA; Forster JS; Bell JG; Dick JR; Younger I; Kennedy DO
    Nutrients; 2016 Feb; 8(2):86. PubMed ID: 26867200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men.
    Kelley DS; Siegel D; Vemuri M; Chung GH; Mackey BE
    J Nutr; 2008 Jan; 138(1):30-5. PubMed ID: 18156400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefit of docosahexaenoic acid for the adult brain in aging and dementia.
    Salem N; Vandal M; Calon F
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jan; 92():15-22. PubMed ID: 25457546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology in health foods: effects of arachidonic acid and docosahexaenoic acid on the age-related decline in brain and cardiovascular system function.
    Kiso Y
    J Pharmacol Sci; 2011; 115(4):471-5. PubMed ID: 21436600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
    Geleijnse JM; Giltay EJ; Kromhout D
    Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study.
    Vauzour D; Scholey A; White DJ; Cohen NJ; Cassidy A; Gillings R; Irvine MA; Kay CD; Kim M; King R; Legido-Quigley C; Potter JF; Schwarb H; Minihane AM
    Am J Clin Nutr; 2023 Aug; 118(2):369-381. PubMed ID: 37315924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of DHA Supplementation on Hippocampal Volume and Cognitive Function in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial.
    Zhang YP; Miao R; Li Q; Wu T; Ma F
    J Alzheimers Dis; 2017; 55(2):497-507. PubMed ID: 27716665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?
    Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.